Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know

Shares of Sagimet Biosciences Inc. (SGMT) have gained 70.6% over the past four weeks to close the last trading session at $5.56, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$29.86 indicates a potential upside of 437.1%.The mean estimate comprises seven short-term price targets with a standard deviation of $20.44. While the lowest estimate of$5 indicates a 10.1% decline from ...